Open AccessGenomic Dissection of Hurthle Cell Carcinoma Reveals a Unique Class of Thyroid Malignancy
Author(s) -
Ian Ganly,
Julio Ricarte Filho,
Stephanie Eng,
Ronald Ghossein,
Luc G.T. Morris,
Yupu Liang,
Nicholas D. Socci,
Kasthuri Kannan,
Qianxing Mo,
James A. Fagin,
Timothy A. Chan
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-3539
Subject(s) - hras , thyroid cancer , kras , neuroblastoma ras viral oncogene homolog , papillary thyroid cancer , cancer research , pax8 , malignancy , cancer , thyroid carcinoma , thyroid , wnt signaling pathway , medicine , biology , pathology , colorectal cancer , gene , genetics , transcription factor
Hurthle cell cancer (HCC) is an understudied cancer with poor prognosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom